What do you do when paternity tests or past mistakes change relationships forever? Asking Eric provides guidance on moving ...

GeneDx Corp's 2024 success story: profitability, 100x returns, NICU market expansion, pediatric neurology diagnostics, and ...

Large and rare duplications and deletions in a chromosome region known as 22q11.2 , which involves genes that regulate cardiac development, are linked ...

After Linda Nolan's tragic death at 65, the Nolan sisters' cancer 'curse' has been revisited, as well as their efforts to ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, will provide an update to the investment community, ...

We recently published a list of 15 Important AI News and Ratings on Investors’ Radar. In this article, we are going to take a ...

Mohbad's widow, Omowunmi has accused her late husband's father, Joseph Aloba, of avoiding a DNA test to resolve the dispute ...

The Chicago health tech company's founder is "100% convinced" that in the coming years, it will be virtually impossible for a ...

The company will be the first to integrate whole genome sequencing (WGS) into Epic's Aura platform, further advancing access ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

A team of British scientists has found that a blood test to detect circulating tumour DNA (ctDNA) may help predict lung ...

New Delhi, January 13 (IANS): A team of British scientists has found that a blood test used to detect circulating tumour DNA can predict the outcome of lung cancer. Circulating tumour DNA (ctDNA) is ...